高龄老人血清尿酸水平与代谢综合征的相关性分析

doi:10.3969/j.issn.1003-9198.2023.11.005

Abstract

Abstract: Objective To explore the relationship of the serum uric acid(UA) level with metabolic syndrome(MS) in the elderly aged ≥80 years old. Methods A total of 1013 elderly aged ≥80 years old from the Health Management Center of Jiangsu Provincial Geriatric Hospital were enrolled in this study.The serum level of UA was detected, and the MS were evaluated. Pearson correlation and Logistic regression were used to explore the relationship of serum UA level with MS. Results Among 1013 elderly aged≥80 years old, there were 269 (26.6%) cases of hyperuricemia, 210(20.7%) cases of MS. The level of serum UA was positively correlated with age, body mass index, triglycerides and MS, while negatively correlated with fasting plasma glucose and high-density lipoprotein cholesterol. High level of UA was an independent risk factor for MS. Conclusions In the elderly aged ≥80 years old, the level of UA is independently related to MS.

Key words: aged, hyperuricemia, metabolic syndrome

CLC Number:

R 589

ZHENG Hui, WANG Hui, YIN Hong-li, YIN Dong-hua, CHENG Yang, WANG Ying. Correlation of serum uric acid level with metabolic syndrome in elderly aged≥80 years old[J]. Practical Geriatrics, 2023, 37(11): 1099-1102.

References

[1] DALBETH N, MERRIMAN T R, STAMP L K. Gout[J]. Lancet, 2016,388(10055):2039-2052.
[2] FU SH,YAO Y,ZHAO Y, et al. Relationships of hyperhomocysteinemia and hyperuricemia with metabolic syndrome and renal function in Chinese centenarians[J].Front Endocrinol :Lausanne, 2018, 9: 502.
[3] CHEN X M,YOKOSE C,RAI S K, et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The National Health and Nutrition Examination Survey, 2007-2016[J].Arthritis Rheumatol, 2019, 71(6): 991-999.
[4] EVERT J, LAWLER E, BOGAN H, et al. Morbidity profiles of centenarians: survivors, delayers, and escapers[J].J Gerontol A Biol Sci Med Sci, 2003, 58(3): 232-237.
[5] QIN X H, HUO Y,XIE D, et al. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials[J].Clin Nutr, 2013, 32(5): 722-727.
[6] FOROUHI N G, SATTAR N.CVD risk factors and ethnicity-a homogeneous relationship?[J].Atheroscler Suppl, 2006, 7(1): 11-19.
[7] ESTEGHAMATI A, HAFEZI-NEJAD N, ZANDIEH A, et al. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease[J]. J Cardiol, 2014, 64(4): 290-296.
[8] 中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12(3):156-161.
[9] MA Y C, ZUO L, CHEN J H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J].J Am Soc Nephrol, 2006, 17(10): 2937-2944.
[10] SCHULTZ A B, EDINGTON D W.Analysis of the association between metabolic syndrome and disease in a workplace population over time[J]. Value Health, 2010, 13(2):258-264.
[11] BARDIN T, RICHETTE P.Definition of hyperuricemia and gouty conditions[J]. Curr Opin Rheumatol, 2014, 26(2): 186-191.
[12] DESIDERI G, CASTALDO G, LOMBARDI A, et al. Is it time to revise the normal range of serum uric acid levels? [J]. Eur Rev Med Pharmacol Sci, 2014, 18(9):1295-1306.
[13] SHLIPAK M G, KATZ R, KESTENBAUM B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J]. Atherosclerosis, 2009, 204(1):298-303.
[14] LIU M, WANG J H, ZENG J, et al. Relationship between serum uric acid level and mild cognitive impairment in Chinese community elderly[J]. BMC Neurol, 2017, 17(1): 146.
[15] LIU R, HAN C, WU D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis[J]. Biomed Res Int, 2015, 2015: 762820.
[16] KUMAR A U A, BROWNE L D, LI X, et al. Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: a cohort study[J]. PLoS One, 2018, 13(5): e0198197.
[17] FU S H, PING P, LUO L M, et al. Deep analyses of the associations of a series of biomarkers with insulin resistance, metabolic syndrome, and diabetes risk in nondiabetic middle-aged and elderly individuals: results from a Chinese community-based study[J]. Clin Interv Aging, 2016, 11: 1531-1538.
[18] FORD E S, GILES W H, DIETZ W H.Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287(3): 356-359.
[19] VAN V J V, NUOTIO M-L, SLAGTER S N, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies[J]. BMC Endocr Disord, 2014, 14: 9.
[20] WILLCOX D C, WILLCOX B J, POON L W. Centenarian studies: important contributors to our understanding of the aging process and longevity[J]. Curr Gerontol Geriatr Res, 2010, 2010: 484529.
[21] ZHANG L, WAN Q L, ZHOU Y M, et al. Age-related and gender-stratified differences in the association between high triglyceride and risk of hyperuricemia[J]. Lipids Health Dis, 2019, 18(1): 147.
[22] AL-DAGHRI N M, AL-ATTAS OMAR S, WANI K, et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in Saudi type 2 diabetic patients[J]. Sci Rep, 2017, 7(1): 12104.
[23] ZHANG J X, ZHANG Y P, WU Q N, et al. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes[J]. Endocrine, 2015, 48(1): 135-142.
[24] NORVIK J V, STORHAUG H M, YTREHUS K, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study[J]. BMC Cardiovasc Disord, 2016, 16: 85.
[25] KERNER A, AVIZOHAR O, SELLA R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome[J]. Arterioscler Thromb Vasc Biol, 2005, 25(1): 193-197.

Correlation of serum uric acid level with metabolic syndrome in elderly aged≥80 years old

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	LI Jiang, QIU Yan, WANG Ting, WANG Dan, YU Yifan, PU Lingli, BU Ling. Correlation between preoperative SII/ALB and clinicopathologic features in elderly patients with lung adenocarcinoma [J]. Practical Geriatrics, 2024, 38(9): 893-896.
[2]	DAI Jing, CUI Yan. Correlation between glycosylated hemoglobin variability and cognitive dysfunction in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(9): 931-935.
[3]	ZHENG Hong, QI Zhenbo, XU Peng, XU Jie, YU Xinyu, ZANG Yanan, ZHANG Zhaoyan. Effects of hypnotics on cognition function and daytime sleepiness in the elderly [J]. Practical Geriatrics, 2024, 38(9): 936-939.
[4]	ZHANG Xingxing, ZHANG Haiyang, HE Xiaojing, LU Xiang. Investigation on the relationship between different physical indexes and the risk of diabetes mellitus in the elderly [J]. Practical Geriatrics, 2024, 38(9): 940-943.
[5]	NI Hongyan, CHEN Yun, ZHANG Qibing, MA Yiming, XIE Chenglan. Effects of electroacupuncture on cognitive function and inflammatory factors in elderly patients undergoing lower limb orthopedic surgery during the perioperative period [J]. Practical Geriatrics, 2024, 38(9): 944-947.
[6]	LI Xiaomin, LI Xiaolin, LI Jie, WU Lei, HAO Ranran. Efficiency influencing factors of transanal double-balloon enteroscopy in elderly patients [J]. Practical Geriatrics, 2024, 38(9): 958-961.
[7]	CAI Huicui, CHEN Yan, WANG Yan, YE Jinjun, ZHU Yuying. Effects of diversified health education model with simple respiratory function exercise on cancer-related fatigue and compliance behavior in elderly patients with lung cancer receiving radiotherapy [J]. Practical Geriatrics, 2024, 38(9): 968-972.
[8]	WANG Xiaojiao, WANG Ning, CUI Hong, YE Tong, WANG Xiaoming. Influence of exercise rehabilitation in elderly patients with mild to moderate chronic heart failure [J]. Practical Geriatrics, 2024, 38(8): 775-778.
[9]	SHEN Chenjun, WANG Xiaoqing, TANG Degang, NING Ping. Correlation between standardized uric acid and renal function in elderly patients with chronic kidney disease aged 90 and over [J]. Practical Geriatrics, 2024, 38(8): 779-782.
[10]	HAO Shijie, ZOU Jianpeng, WEI Chen, LIU Qingjiang. Effect of comprehensive respiratory training on hypokinetic dysarthria in elderly patients with Parkinson’s disease [J]. Practical Geriatrics, 2024, 38(8): 783-787.
[11]	XIANG Chao, LUO Caidong. Analysis of the diagnostic value of T wave change of avL lead for the degree of coronary artery stenosis in elderly patients with coronary heart disease [J]. Practical Geriatrics, 2024, 38(8): 788-791.
[12]	LI Huiying, CAI Lili, ZHU Qiwei. Predictive value of plasma N-terminal pro-brain natriuretic peptide for prognosis in patients aged ≥80 years old with left ventricular hypertrophy [J]. Practical Geriatrics, 2024, 38(8): 797-801.
[13]	WANG Xinping, XIE Baimei, WEI Guo, YE Xiaoli, ZHAO Yayun, TAN Xiaotian. Expression levels and clinical significance of serum S100A9 and sCD163 in elderly patients with idiopathic interstitial pneumonia [J]. Practical Geriatrics, 2024, 38(8): 802-807.
[14]	LIU Meijuan, WANG Ning, WANG Dong, LU Fangzhou, LIU Juan. Effect of low-dose lidocaine combined with propofol on motor evoked potential in elderly patients undergoing intracranial tumor resection [J]. Practical Geriatrics, 2024, 38(8): 808-811.
[15]	LI Jingbing, WANG Huijun, WANG Shaoying, ZHAO Can, WANG Lidi, CAO Yujiao. Impacts of pentoxifylline combined with lipoic acid intervention on physical function and quality of life in elderly patients with frailty syndrome [J]. Practical Geriatrics, 2024, 38(8): 812-815.